AllianceBernstein’s Niagen Bioscience NAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.05M Buy
322,961
+64,341
+25% +$347K ﹤0.01% 1989
2025
Q4
$1.64M Buy
258,620
+109,500
+73% +$762K ﹤0.01% 2108
2025
Q3
$1.39M Buy
149,120
+98,770
+196% +$997K ﹤0.01% 2194
2025
Q2
$726K Buy
50,350
+40,300
+401% +$398K ﹤0.01% 2457
2025
Q1
$69.3K Hold
10,050
﹤0.01% 3101
2024
Q4
$53.3K Hold
10,050
﹤0.01% 3182
2024
Q3
$36.7K Hold
10,050
﹤0.01% 3204
2024
Q2
$27.4K Buy
+10,050
New +$33.6K ﹤0.01% 3216
2022
Q2
Sell
-24,100
Closed -$59K 3405
2022
Q1
$59K Sell
24,100
-5,200
-18% -$14.2K ﹤0.01% 3166
2021
Q4
$110K Hold
29,300
﹤0.01% 3182
2021
Q3
$184K Hold
29,300
﹤0.01% 3105
2021
Q2
$289K Buy
29,300
+14,800
+102% +$129K ﹤0.01% 3021
2021
Q1
$135K Sell
14,500
-29,700
-67% -$235K ﹤0.01% 3124
2020
Q4
$212K Hold
44,200
﹤0.01% 2972
2020
Q3
$177K Sell
44,200
-2,700
-6% -$13K ﹤0.01% 2980
2020
Q2
$215K Buy
46,900
+26,300
+128% +$118K ﹤0.01% 2989
2020
Q1
$67K Buy
20,600
+9,900
+93% +$38K ﹤0.01% 3023
2019
Q4
$46K Hold
10,700
﹤0.01% 3097
2019
Q3
$42K Buy
+10,700
New +$45.6K ﹤0.01% 3132

Other funds holding NAGE